HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
50 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ALB
albumin
Chromosome 4 Β· 4q13.3
NCBI Gene: 213Ensembl: ENSG00000163631.20HGNC: HGNC:399UniProt: P02768
784PubMed Papers
22Diseases
0Drugs
20Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
RESEARCH IMPACT
Highly StudiedTrending
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
negative regulation of mitochondrial depolarizationDNA bindingprotein-containing complexGO:0005615hyperthyroxinemiacongenital analbuminemiaEhlers-Danlos syndrome, arthrochalasia typeEhlers-Danlos syndrome, arthrochalasic type
✦AI Summary

Albumin (ALB) is a major serum protein with multifaceted physiological functions centered on transport and metabolic regulation. Structurally, ALB binds water, calcium, sodium, potassium, fatty acids, hormones, bilirubin, and drugs, with its primary function being regulation of blood colloidal osmotic pressure [UniProt]. As the major zinc transporter in plasma, ALB typically binds approximately 80% of circulating plasma zinc, with a binding affinity hierarchy of zinc > calcium > magnesium, and a potential shared binding site at Asp-273 suggesting zinc-calcium transport crosstalk [19021548]. ALB also binds approximately 45% of circulating calcium and magnesium in plasma [UniProt]. Notably, ALB binds bacterial siderophore enterobactin and inhibits enterobactin-mediated iron uptake by E. coli from ferric transferrin, thereby limiting enteric bacterial iron utilization and growth, though it does not prevent aerobactin-mediated iron uptake [6234017]. Beyond transport functions, ALB demonstrates antioxidant activity and bilirubin transport capacity [GO annotations]. Clinically, ALB levels serve as an important biomarker; elevated systemic immune-inflammation index/albumin ratios independently predict worse overall and recurrence-free survival in hepatocellular carcinoma patients undergoing curative resection [39735268]. Additionally, PCT/ALB and CRP/ALB ratios correlate with severity and prognosis in craniocerebral trauma [39165205]. Genetic variants of ALB, including inherited bisalbuminemia, show geographic variation in prevalence [34919010].

Sources cited
1
ALB is the major zinc transporter in plasma, binding approximately 80% of all plasma zinc
PMID: 19021548
2
ALB binds bacterial siderophore enterobactin and inhibits enterobactin-mediated iron uptake by E. coli, but does not prevent aerobactin-mediated uptake
PMID: 6234017
3
SII/ALB ratio independently predicts overall survival and recurrence-free survival in HCC patients undergoing hepatectomy
PMID: 39735268
4
PCT/ALB and CRP/ALB ratios correlate with severity and prognosis of craniocerebral trauma patients
PMID: 39165205
5
Inherited bisalbuminemia ALB variants show geographic variation in prevalence in Chinese populations
PMID: 34919010
Disease Associationsβ“˜22
hyperthyroxinemiaOpen Targets
0.70Strong
congenital analbuminemiaOpen Targets
0.69Moderate
Ehlers-Danlos syndrome, arthrochalasia typeOpen Targets
0.33Weak
Ehlers-Danlos syndrome, arthrochalasic typeOpen Targets
0.33Weak
Abruptio PlacentaeOpen Targets
0.27Weak
genetic disorderOpen Targets
0.19Weak
metabolic diseaseOpen Targets
0.16Weak
hepatocellular carcinomaOpen Targets
0.13Weak
neoplasmOpen Targets
0.12Weak
SepsisOpen Targets
0.12Weak
acute kidney injuryOpen Targets
0.12Weak
cancerOpen Targets
0.12Weak
chronic kidney diseaseOpen Targets
0.11Weak
Alzheimer diseaseOpen Targets
0.11Weak
atrial fibrillationOpen Targets
0.11Weak
CirrhosisOpen Targets
0.11Weak
COVID-19Open Targets
0.11Weak
prostate carcinomaOpen Targets
0.11Weak
HypoalbuminemiaOpen Targets
0.11Weak
deep vein thrombosisOpen Targets
0.11Weak
AnalbuminemiaUniProt
Hyperthyroxinemia, familial dysalbuminemicUniProt
Pathogenic Variants20
NM_000477.7(ALB):c.228_229del (p.Val78fs)Pathogenic
Analbuminemia|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 78
NM_000477.7(ALB):c.412C>T (p.Arg138Ter)Pathogenic
Analbuminemia|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 138
NM_000477.7(ALB):c.1225C>T (p.Gln409Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 409
NM_000477.7(ALB):c.872dup (p.Asn291fs)Pathogenic
Analbuminemia|not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 291
NM_000477.7(ALB):c.1020C>A (p.Cys340Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 340
NM_000477.7(ALB):c.70C>T (p.Arg24Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 24
NM_000477.7(ALB):c.724C>A (p.Arg242Ser)Pathogenic
Hyperthyroidism
β˜…β˜†β˜†β˜†2024β†’ Residue 242
NM_000477.7(ALB):c.714-2A>GPathogenic
Analbuminemia|not provided
β˜…β˜†β˜†β˜†2023
NM_000477.7(ALB):c.1378A>T (p.Lys460Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 460
NM_000477.7(ALB):c.656_659del (p.Lys219fs)Likely pathogenic
Analbuminemia
β˜…β˜†β˜†β˜†2022β†’ Residue 219
NM_000477.7(ALB):c.1098dup (p.Val367fs)Pathogenic
Analbuminemia
β˜†β˜†β˜†β˜†2021β†’ Residue 367
NM_000477.7(ALB):c.1780G>A (p.Glu594Lys)Pathogenic
ALBUMIN B
β˜†β˜†β˜†β˜†2012β†’ Residue 594
NM_000477.7(ALB):c.79+1G>APathogenic
Analbuminemia Baghdad
β˜†β˜†β˜†β˜†2002
NM_000477.7(ALB):c.269T>C (p.Leu90Pro)Pathogenic
Hyperthyroxinemia, familial dysalbuminemic
β˜†β˜†β˜†β˜†1998β†’ Residue 90
NM_000477.7(ALB):c.725G>C (p.Arg242Pro)Pathogenic
Hyperthyroxinemia, familial dysalbuminemic
β˜†β˜†β˜†β˜†1997β†’ Residue 242
NM_000477.7(ALB):c.166C>T (p.Gln56Ter)Pathogenic
Analbuminemia
β˜†β˜†β˜†β˜†1994β†’ Residue 56
NM_000477.7(ALB):c.714G>A (p.Trp238Ter)Pathogenic
Analbuminemia
β˜†β˜†β˜†β˜†1994β†’ Residue 238
NM_000477.7(ALB):c.74A>T (p.Asp25Val)Pathogenic
Alloalbuminemia
β˜†β˜†β˜†β˜†1991β†’ Residue 25
NM_000477.7(ALB):c.1693A>G (p.Lys565Glu)Pathogenic
not specified
β˜†β˜†β˜†β˜†1989β†’ Residue 565
NM_000477.5(ALB):c.71G>C (p.Arg24Pro)Pathogenic
Alloalbuminemia
β˜†β˜†β˜†β˜†1987β†’ Residue 24
View on ClinVar β†—
Related Genes
FN1Protein interaction100%LALBAProtein interaction100%FCGRTProtein interaction100%CST3Protein interaction100%RBP4Protein interaction100%CSN2Protein interaction100%
Tissue Expression6 tissues
Liver
100%
Lung
0%
Brain
0%
Ovary
0%
Heart
0%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
ALBFN1LALBAFCGRTCST3RBP4CSN2
PROTEIN STRUCTURE
Preparing viewer…
PDB6YG9 Β· 1.89 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.58Moderately Constrained
pLIβ“˜
0.11Tolerant
Observed/Expected LoF0.42 [0.31–0.58]
RankingsWhere ALB stands among ~20K protein-coding genes
  • #253of 20,598
    Most Researched784 Β· top 5%
  • #2,172of 5,498
    Most Pathogenic Variants20
  • #3,828of 17,882
    Most Constrained (LOEUF)0.58 Β· top quartile
Genes detectedALB
Sources retrieved50 papers
Response timeβ€”
πŸ“„ Sources
50β–Ό
1
Alisol B regulates AMPK/mTOR/SREBPs via directly targeting VDAC1 to alleviate hyperlipidemia.
PMID: 38520833
Phytomedicine Β· 2024
1.00
2
Predictive Value of the Neutrophil-to-Lymphocyte Ratio/Serum Albumin for All-Cause Mortality in Critically Ill Patients Suffering from COPD.
PMID: 40098661
Int J Chron Obstruct Pulmon Dis Β· 2025
0.96
3
Structure-affinity-pharmacokinetics relationships of
PMID: 39153354
Nucl Med Biol Β· 2024
0.90
4
Early Lactate/Albumin and Procalcitonin/Albumin Ratios as Predictors of 28-Day Mortality in ICU-Admitted Sepsis Patients: A Retrospective Cohort Study.
PMID: 37518978
Med Sci Monit Β· 2023
0.90
5
Carbamylated Albumin, Heart Failure, and Mortality in Patients Undergoing Coronary Angiography.
PMID: 40105890
Clin Chem Β· 2025
0.88